Haleon PLC (GB:HLN) has released an update.
Haleon PLC has announced the purchase of 656,800 of its own shares for cancellation as part of a share buyback program initiated on August 1, 2024. After the transaction, the company’s registered share capital consists of over 9 billion ordinary shares. This move is part of Haleon’s effort to manage its capital effectively while maintaining a strong presence in the consumer health market with well-known brands like Advil and Sensodyne.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
